Cardiome Pharma Corporation (CRME)
Cardiome Pharma Corporation Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -5.90M | -7.16M | -7.72M | -7.14M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Depreciation, Depletion, Amortization | 0.27M | 0.27M | 0.28M | 0.27M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Other Non-Cash Items | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Non-Cash Items | 0.27M | 0.27M | 0.28M | 0.27M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | -0.60M | -0.19M | -1.02M | -0.81M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Other Operating Activities | 0.32M | 0.68M | 0.44M | 0.40M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Net Cash from Operating Activities | -5.90M | -6.40M | -8.03M | -7.27M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.04M | -0.10M | -0.42M | -0.11M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Acquisitions, Divestitures | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Other Investing Activities | -0.04M | -0.05M | -0.07M | -0.18M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | -0.07M | -0.16M | -0.49M | -0.29M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Debt Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Equity Issued | 0.00 | 0.00 | 0.00 | 0.35M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Other Financing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Financing Activities | 0.00 | 0.00 | 0.00 | 0.35M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Foreign Exchange Effects | 0.07M | -0.20M | 0.02M | 0.13M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Net Change in Cash & Cash Equivalents | -5.90M | -6.77M | -8.49M | -7.08M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Cash at beginning of period | 76.88M | 48.64M | 54.54M | 61.31M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Cash at end of period | 48.64M | 54.54M | 61.31M | 69.80M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
